The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 418-424

  Raad, Issam ^a   Darouiche, Rabih ^a   Hachem, Ray ^a   Mansouri, Mohammad ^a   Bodey, Gerald P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; RIFAMPICIN;

ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CATHETER INFECTION; DRUG EFFICACY; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS;

EID: 0030033266     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.418     Document Type: Article

References (14)

1. Farr BM. Prevention and management of vascular catheter infections. Crit Care Med 1994;6:29-42.
2. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital infections. Boston: Little, Brown, 1992:849-98.
3. Stamm WE, Martin SM, Bennett JV. Epidemiology of nosocomial infections due to gram-negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis 1977;136(suppl):S151-60.
4. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis 1988;148:57-62.
5. Asher EF, Oliver BG, Fry DE. Urinary tract infections in the surgical patient. Am Surg 1988;54:466-9.
6. Maki DG. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Bisno SL, Waldvogel FA, eds. Infections associated with indwelling medical devices. Washington, DC: American Society for Microbiology, 1989:161-77.
7. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400-7.
8. Costerton JW, Irvin RT, Cheng KJ. The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 1981;35:299-324.
9. Davenport DS, Massanari RM, Pfaller MA, Bale MJ, Streed SA, Hierholzer WJ. Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J Infect Dis 1986;153:332-9.
10. Sheth NK, Franson TR, Sohnle PG. Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet 1985;2:1266-8.
11. Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 1990;161:37-40.
12. Costerton JW, Lappin-Scott HM. Behavior of bacteria in biofilms. Am Soc Microbiol News 1989;55:650-4.
13. Raad II, Hohn DC, Gilbreath J, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-8.
14. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981;70:739-44.